354 related articles for article (PubMed ID: 19543901)
1. A novel point mutation at donor splice-site in intron 42 of type III collagen gene resulting in the inclusion of 30 nucleotides into the mature mRNA in a case of vascular type of Ehlers-Danlos syndrome.
Okita H; Ikeda Y; Mitsuhashi Y; Namikawa H; Kitamura Y; Hamasaki Y; Yamazaki S; Hatamochi A
Arch Dermatol Res; 2010 Jul; 302(5):395-9. PubMed ID: 19543901
[TBL] [Abstract][Full Text] [Related]
2. A novel point mutation in type III collagen gene resulting in exon 24 skipping in a case of vascular type Ehlers-Danlos syndrome.
Okamoto O; Ando T; Watanabe A; Sato F; Mimata H; Shimada T; Fujiwara S
Arch Dermatol Res; 2008 Oct; 300(9):525-9. PubMed ID: 18779970
[TBL] [Abstract][Full Text] [Related]
3. Clinical and genetic features of 20 Japanese patients with vascular-type Ehlers-Danlos syndrome.
Shimaoka Y; Kosho T; Wataya-Kaneda M; Funakoshi M; Suzuki T; Hayashi S; Mitsuhashi Y; Isei T; Aoki Y; Yamazaki K; Ono M; Makino K; Tanaka T; Kunii E; Hatamochi A
Br J Dermatol; 2010 Oct; 163(4):704-10. PubMed ID: 20518783
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis of vascular Ehlers-Danlos syndrome in Italy: clinical findings and novel COL3A1 mutations.
Drera B; Zoppi N; Ritelli M; Tadini G; Venturini M; Wischmeijer A; Nicolazzi MA; Musumeci A; Penco S; Buscemi L; Crivelli S; Danesino C; Clementi M; Calzavara-Pinton P; Viglio S; Valli M; Barlati S; Colombi M
J Dermatol Sci; 2011 Dec; 64(3):237-40. PubMed ID: 22019127
[No Abstract] [Full Text] [Related]
5. Vascular Ehlers-Danlos syndrome: a case with fatal outcome.
Morais P; Mota A; Eloy C; Lopes JM; Torres F; Palmeiro A; Tavares P; Azevedo F
Dermatol Online J; 2011 Apr; 17(4):1. PubMed ID: 21549076
[TBL] [Abstract][Full Text] [Related]
6. [Vascular Ehlers-Danlos syndromes--biochemical and molecular-genetic investigations].
Lund AM
Ugeskr Laeger; 2006 Feb; 168(9):915-20. PubMed ID: 16513057
[TBL] [Abstract][Full Text] [Related]
7. A novel mutation screening system for Ehlers-Danlos Syndrome, vascular type by high-resolution melting curve analysis in combination with small amplicon genotyping using genomic DNA.
Naing BT; Watanabe A; Shimada T
Biochem Biophys Res Commun; 2011 Feb; 405(3):368-72. PubMed ID: 21219851
[TBL] [Abstract][Full Text] [Related]
8. Further evidence that the failure to cleave the aminopropeptide of type I procollagen is the cause of Ehlers-Danlos syndrome type VII.
Ho KK; Kong RY; Kuffner T; Hsu LH; Ma L; Cheah KS
Hum Mutat; 1994; 3(4):358-64. PubMed ID: 8081389
[TBL] [Abstract][Full Text] [Related]
9. Aberrant splicing of the type III procollagen mRNA leads to intracellular degradation of the protein in a patient with Ehlers-Danlos type IV.
Thakker-Varia S; Anderson DW; Kuivaniemi H; Tromp G; Shin HG; van der Rest M; Glorieux FH; Ala-Kokko L; Stolle CA
Hum Mutat; 1995; 6(2):116-25. PubMed ID: 7581395
[TBL] [Abstract][Full Text] [Related]
10. Single-strand conformation polymorphism (SSCP) analysis of the COL3A1 gene detects a mutation that results in the substitution of glycine 1009 to valine and causes severe Ehlers-Danlos syndrome type IV.
Nuytinck L; De Paepe A; Renard JP; Adriaens F; Leroy J
Hum Mutat; 1994; 3(3):268-74. PubMed ID: 8019562
[TBL] [Abstract][Full Text] [Related]
11. Haploinsufficiency for one COL3A1 allele of type III procollagen results in a phenotype similar to the vascular form of Ehlers-Danlos syndrome, Ehlers-Danlos syndrome type IV.
Schwarze U; Schievink WI; Petty E; Jaff MR; Babovic-Vuksanovic D; Cherry KJ; Pepin M; Byers PH
Am J Hum Genet; 2001 Nov; 69(5):989-1001. PubMed ID: 11577371
[TBL] [Abstract][Full Text] [Related]
12. [Genetic analysis in the clinical diagnosis of Ehlers-Danlos syndrome type IV].
Chen B; Guan YQ; Wu XL; Qi YX; Yu HX; Li JX; Zhang J
Zhonghua Yi Xue Za Zhi; 2011 Apr; 91(16):1122-4. PubMed ID: 21609597
[TBL] [Abstract][Full Text] [Related]
13. Ehlers-Danlos syndrome type IV, vascular type, which demonstrated a novel point mutation in the COL3A1 gene.
Sadakata R; Hatamochi A; Kodama K; Kaga A; Yamaguchi T; Soma T; Usui Y; Nagata M; Ohtake A; Hagiwara K; Kanazawa M
Intern Med; 2010; 49(16):1797-800. PubMed ID: 20720362
[TBL] [Abstract][Full Text] [Related]
14. Temperature sensitivity of aberrant RNA splicing with a mutation in the G+5 position of intron 37 of the gene for type III procollagen from a patient with Ehlers-Danlos syndrome type IV.
Wu Y; Kuivaniemi H; Tromp G; Strobel D; Romanic AM; Prockop DJ
Hum Mutat; 1993; 2(1):28-36. PubMed ID: 8477261
[TBL] [Abstract][Full Text] [Related]
15. Ehlers-Danlos syndrome type IV: phenotypic consequences of a splicing mutation in one COL3A1 allele.
Sillence DO; Chiodo AA; Campbell PE; Cole WG
J Med Genet; 1991 Dec; 28(12):840-5. PubMed ID: 1757960
[TBL] [Abstract][Full Text] [Related]
16. Elastic fiber abnormalities in hypermobility type Ehlers-Danlos syndrome patients with tenascin-X mutations.
Zweers MC; Dean WB; van Kuppevelt TH; Bristow J; Schalkwijk J
Clin Genet; 2005 Apr; 67(4):330-4. PubMed ID: 15733269
[TBL] [Abstract][Full Text] [Related]
17. Ehlers-Danlos syndrome, vascular type: a novel missense mutation in the COL3A1 gene.
Masuno M; Watanabe A; Naing BT; Shimada T; Fujimoto W; Ninomiya S; Ueda Y; Kadota K; Kotaka T; Kondo E; Yamanouchi Y; Inoue M; Ouchi K; Kuroki Y
Congenit Anom (Kyoto); 2012 Dec; 52(4):207-10. PubMed ID: 23181496
[TBL] [Abstract][Full Text] [Related]
18. The mRNA and the activity of lysyl hydroxylase are up-regulated by the administration of ascorbate and hydralazine to human skin fibroblasts from a patient with Ehlers-Danlos syndrome type VI.
Yeowell HN; Walker LC; Marshall MK; Murad S; Pinnell SR
Arch Biochem Biophys; 1995 Aug; 321(2):510-6. PubMed ID: 7646078
[TBL] [Abstract][Full Text] [Related]
19. Abnormal formation of collagen cross-links in skin fibroblasts cultured from patients with Ehlers-Danlos syndrome type VI.
Pasquali M; Still MJ; Vales T; Rosen RI; Evinger JD; Dembure PP; Longo N; Elsas LJ
Proc Assoc Am Physicians; 1997 Jan; 109(1):33-41. PubMed ID: 9010914
[TBL] [Abstract][Full Text] [Related]
20. A new COL3A1 mutation in Ehlers-Danlos syndrome type IV.
Eder J; Laccone F; Rohrbach M; Giunta C; Aumayr K; Reichel C; Trautinger F
Exp Dermatol; 2013 Mar; 22(3):231-4. PubMed ID: 23489429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
